Literature DB >> 19223871

Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression.

Jason B Tatom1, David B Wang, Robert D Dayton, Omar Skalli, Michael L Hutton, Dennis W Dickson, Ronald L Klein.   

Abstract

Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1-2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223871      PMCID: PMC2835101          DOI: 10.1038/mt.2009.3

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  27 in total

1.  TDP-43 is deposited in the Guam parkinsonism-dementia complex brains.

Authors:  Masato Hasegawa; Tetsuaki Arai; Haruhiko Akiyama; Takashi Nonaka; Hiroshi Mori; Tomoyo Hashimoto; Mineo Yamazaki; Kiyomitsu Oyanagi
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

Review 2.  Frontotemporal lobar degeneration: current concepts in the light of recent advances.

Authors:  Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Brain Pathol       Date:  2007-01       Impact factor: 6.508

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

4.  A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.

Authors:  J B Leverenz; C E Yu; T J Montine; E Steinbart; L M Bekris; C Zabetian; L K Kwong; V M-Y Lee; G D Schellenberg; T D Bird
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

Review 5.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Front Biosci       Date:  2008-01-01

Review 6.  TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease.

Authors:  Linda K Kwong; Manuela Neumann; Deepak M Sampathu; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2007-05-10       Impact factor: 17.088

7.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

9.  Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43.

Authors:  Yong-Jie Zhang; Ya-fei Xu; Chad A Dickey; Emanuele Buratti; Francisco Baralle; Rachel Bailey; Stuart Pickering-Brown; Dennis Dickson; Leonard Petrucelli
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

10.  Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.

Authors:  Maria Filimonenko; Susanne Stuffers; Camilla Raiborg; Ai Yamamoto; Lene Malerød; Elizabeth M C Fisher; Adrian Isaacs; Andreas Brech; Harald Stenmark; Anne Simonsen
Journal:  J Cell Biol       Date:  2007-11-05       Impact factor: 10.539

View more
  45 in total

Review 1.  Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma.

Authors:  Brandon E Gavett; Robert A Stern; Ann C McKee
Journal:  Clin Sports Med       Date:  2011-01       Impact factor: 2.182

2.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

3.  Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.

Authors:  David B Wang; Robert D Dayton; Phillip P Henning; Cooper D Cain; Li Ru Zhao; Lisa M Schrott; Elysse A Orchard; David S Knight; Ronald L Klein
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

Review 4.  TDP-43 and frontotemporal dementia.

Authors:  William T Hu; Murray Grossman
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

Review 5.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

Review 6.  Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.

Authors:  T F Gendron; K A Josephs; L Petrucelli
Journal:  Neuropathol Appl Neurobiol       Date:  2010-02-19       Impact factor: 8.090

Review 7.  TDP43 and RNA instability in amyotrophic lateral sclerosis.

Authors:  Kaitlin Weskamp; Sami J Barmada
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

8.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

9.  ALS spinal neurons show varied and reduced mtDNA gene copy numbers and increased mtDNA gene deletions.

Authors:  Paula M Keeney; James P Bennett
Journal:  Mol Neurodegener       Date:  2010-05-26       Impact factor: 14.195

10.  Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.

Authors:  Hongxia Zhou; Cao Huang; Han Chen; Dian Wang; Carlisle P Landel; Pedro Yuxing Xia; Robert Bowser; Yong-Jian Liu; Xu Gang Xia
Journal:  PLoS Genet       Date:  2010-03-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.